Participant expectancies in double-blind randomized placebo-controlled trials: potential limitations to trial validity. (Q37737462)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20421243%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

review article

1 reference

title

Participant expectancies in double-blind randomized placebo-controlled trials: potential limitations to trial validity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20421243%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20421243%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

author name string

Ben Colagiuri

series ordinal

1

1 reference

22 August 2017

26 April 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20421243%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20421243%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20421243%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20421243%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

246-255

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20421243%20AND%20SRC:MED&resulttype=core&format=json

Statistics notes. Treatment allocation in controlled trials: why randomise?

1 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1740774510367916

Who is blinded in randomized clinical trials? A study of 200 trials and a survey of authors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774510367916

Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774510367916

Expectations and the placebo effect in clinical drug trials: why we should not turn a blind eye to unblinding, and other cautionary notes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774510367916

Is acupuncture analgesia an expectancy effect? Preliminary evidence based on participants' perceived assignments in two placebo-controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774510367916

Assigned versus perceived placebo effects in nicotine replacement therapy for smoking reduction in Swiss smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774510367916

A controlled clinical trial of ascorbic acid for the common cold

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774510367916

Effects of perceived treatment on quality of life and medical outcomes in a double-blind placebo surgery trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774510367916

The impact of perceived treatment assignment on smoking cessation outcomes among African-American smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774510367916

Expectancy in double-blind placebo-controlled trials: an example from alcohol dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774510367916

Nicotine replacement to reduce cigarette consumption in smokers who are unwilling to quit: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774510367916

Blinding of outcomes in trials of orthopaedic trauma: an opportunity to enhance the validity of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774510367916

Blinded trials taken to the test: an analysis of randomized clinical trials that report tests for the success of blinding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774510367916

How "blind" are double-blind studies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774510367916

How blind is blind? Assessment of patient and doctor medication guesses in a placebo-controlled trial of imipramine and phenelzine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774510367916

Testing for the integrity of blinding in clinical trials: how valid are forced choice paradigms?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774510367916

Randomized trial of the effect of drug presentation on asthma outcomes: the American Lung Association Asthma Clinical Research Centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774510367916

The impact of patient expectations on outcomes in four randomized controlled trials of acupuncture in patients with chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774510367916

Placebos in medicine: placebo use is well known, placebo effect is not

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774510367916

The influence of placebo awareness on stimulant drug response in a double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774510367916

Are randomized control trial outcomes influenced by the inclusion of a placebo group?: a systematic review of nonsteroidal antiinflammatory drug trials for arthritis treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774510367916

Response expectancies in placebo analgesia and their clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774510367916

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774510367916

Open versus hidden medical treatments: The patient's knowledge about a therapy affects the therapy outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774510367916

The influence of instructions and nicotine dose on the subjective and reinforcing effects of smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774510367916

Expectancy and pharmacology influence the subjective effects of nicotine in a balanced-placebo design

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774510367916

Deception in research on the placebo effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774510367916

The antidepressant debate and the balanced placebo trial design: an ethical analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774510367916

Overt versus covert treatment for pain, anxiety, and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774510367916

Mechanisms of the placebo response and their impact on clinical trials and clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774510367916

Placebo and naloxone can alter post-surgical pain by separate mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774510367916

Response variability to analgesics: a role for non-specific activation of endogenous opioids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774510367916

Methodological issues in clinical trials of antidepressant medications: perspectives from psychotherapy outcome research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774510367916

The ethics of placebo-controlled trials: a comparison of inert and active placebo controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774510367916

Placebos, drug effects, and study design: a clinician's guide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774510367916

Blinding effectiveness and association of pretreatment expectations with pain improvement in a double-blind randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774510367916

Methods of blinding in reports of randomized controlled trials assessing pharmacologic treatments: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774510367916

The revised CONSORT statement for reporting randomized trials: explanation and elaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774510367916

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774510367916

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774510367916

Perceived treatment, feedback, and placebo effects in double-blind RCTs: an experimental analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774510367916

Influence of the method of drug administration on analgesic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774510367916

21 January 2018

Identifiers

DOI

10.1177/1740774510367916

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20421243%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference